Results 71 to 80 of about 29,772 (222)

Using Q-methodology to understand the perspectives and practical experiences of dermatologists about treatment difficulties of cutaneous leishmaniasis

open access: yesBMC Infectious Diseases, 2020
Background During the outbreak of cutaneous leishmaniasis in the Kurdistan Region of Iraq that started in 2015, the course of the disease and the treatment were not consistent with the available literature.
Dindar S. Qurtas, Nazar Pauls Shabila
doaj   +1 more source

Cutaneous leishmaniasis in Pakistan

open access: yesDermatology Online Journal, 2005
Leishmaniasis is a major health problem worldwide. It is also a particular problem in the rural areas of Pakistan. The disease occurs in varying presentations, from the self-limited and even self-healing cutaneous forms to fatal systemic disease. Lesions of cutaneous leishmaniasis may occur anywhere on the body but the most likely sites are the exposed
Khan, Shiraz Jamal, Muneeb, Syed
openaire   +4 more sources

Cell membrane‐coated nanoparticles for dermatological diseases

open access: yesVIEW, Volume 7, Issue 3, June 2026.
Skin disorders are challenging to treat due to complex barrier functions and limited conventional therapies. Biomimetic cell membrane‐coated nanoparticles (CM‐NPs) offer a superior nanomedicine approach by evading immune detection and enabling precise targeting.
Shuaijun Zou, Baojie Zhang, Yuanjie Zhu
wiley   +1 more source

The efficacy of thermotherapy to treat cutaneous leishmaniasis in Colombia: a comparative observational study in an operational setting.

open access: yes, 2009
An open label, comparative study to compare the efficacy of thermotherapy to meglumine antimoniate in treating cutaneous leishmaniasis patients in an operational context was carried out in Chaparral, Colombia.
Reithinger, Richard   +8 more
core   +1 more source

Rifampicin in Cutaneous Leishmaniasis

open access: yesJournal of International Medical Research, 1978
A study is described which aimed at assessing the efficacy of rifampicin in the treatment of cutaneous leishmaniasis. A total of thirteen patients suffering from this condition were admitted to the study and were given rifampicin 600 mg daily. Three patients dropped out due to reasons unconnected with the trial and one patient left when the lesions ...
openaire   +2 more sources

Treatment of localised cutaneous Leishmania tropica infection in Aleppo, Syria and drug sensitivity of clinical isolates [PDF]

open access: yes
Anthroponotic cutaneous leishmaniasis caused by Leishmania tropica has been endemic in Aleppo, Syria for centuries. The first modem description of the disease was also done in Aleppo.
Abazid, Nizar
core   +1 more source

Transmission of cutaneous leishmaniasis by sand flies is enhanced by regurgitation of fPPG [PDF]

open access: yes, 2004
Sand flies are the exclusive vectors of the protozoan parasite Leishmania, but the mechanism of transmission by fly bite has not been determined nor incorporated into experimental models of infection.
Bates, Paul A.   +18 more
core   +1 more source

Kidney involvement in leishmaniasis—a review

open access: yesBrazilian Journal of Infectious Diseases, 2014
Leishmaniasis is an infectious disease caused by protozoa of the genus Leishmania transmitted by insects of the genus Lutzomyia sp. or Phlebotomus sp.
Geraldo Bezerra da Silva Junior   +2 more
doaj   +1 more source

Evaluation of Metal Nanoparticles Using ICP‐OES in Hairs of Patients With Frontal Fibrosing Alopecia and Comparison With Control Group

open access: yesJournal of Cosmetic Dermatology, Volume 25, Issue 6, June 2026.
ABSTRACT Background Frontal fibrosing alopecia (FFA) is an increasingly prevalent scarring alopecia potentially linked to environmental factors such as nanoparticles (NPs) in skincare and sunscreens. Objectives This case–control study aimed to quantify titanium, zinc, aluminum, and iron concentrations in hair shafts of FFA patients versus controls ...
Farnaz Ahmadpour   +4 more
wiley   +1 more source

Effect of village-wide use of long-lasting insecticidal nets on visceral Leishmaniasis vectors in India and Nepal: a cluster randomized trial. [PDF]

open access: yes, 2010
BACKGROUND: Visceral leishmaniasis (VL) control in the Indian subcontinent is currently based on case detection and treatment, and on vector control using indoor residual spraying (IRS).
Mark Rowland   +54 more
core   +1 more source

Home - About - Disclaimer - Privacy